These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10198900)

  • 21. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A turn of the sulfatide in Alzheimer's disease.
    Irizarry MC
    Ann Neurol; 2003 Jul; 54(1):7-8. PubMed ID: 12838515
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proteins of Alzheimer's disease].
    Piekiełko A
    Postepy Biochem; 1999; 45(2):116-22. PubMed ID: 10581635
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
    Blain JF; Poirier J
    Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abeta predictor of Alzheimer disease symptoms.
    Sephton CF; Yu G
    Arch Neurol; 2008 Jul; 65(7):875-6. PubMed ID: 18625853
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.
    Brendza RP; Bales KR; Paul SM; Holtzman DM
    Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304
    [No Abstract]   [Full Text] [Related]  

  • 29. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.
    Navarro A; Del Valle E; Astudillo A; González del Rey C; Tolivia J
    Exp Neurol; 2003 Dec; 184(2):697-704. PubMed ID: 14769361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The amyloid beta protein generating mechanism simultaneously generates several other peptides in Alzheimer disease--discovery of new notch-beta peptide and the possibility of its use as a marker for the diagnosis of Alzheimer disease].
    Okochi M; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):87-96. PubMed ID: 12701215
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroscience. Possible role for environmental copper in Alzheimer's disease.
    Marx J
    Science; 2003 Aug; 301(5635):905. PubMed ID: 12920276
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease: genetic variables and risk.
    Secko D
    CMAJ; 2005 Mar; 172(5):627. PubMed ID: 15738483
    [No Abstract]   [Full Text] [Related]  

  • 35. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation.
    Kaether C; Haass C
    J Cell Biol; 2004 Dec; 167(5):809-12. PubMed ID: 15583026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bringing amyloid into focus.
    Golde TE; Bacskai BJ
    Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
    [No Abstract]   [Full Text] [Related]  

  • 37. Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences.
    Bateman DA; Chakrabartty A
    Biopolymers; 2004; 76(1):4-14. PubMed ID: 14997469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The amyloid cascade hypothesis.
    Korczyn AD
    Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation and Alzheimer disease: the good, the bad, and the ugly.
    Weninger SC; Yankner BA
    Nat Med; 2001 May; 7(5):527-8. PubMed ID: 11329045
    [No Abstract]   [Full Text] [Related]  

  • 40. A fluid connection: cholesterol and Abeta.
    Wolozin B
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5371-3. PubMed ID: 11344276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.